The 2018 Farm Bill has legalized hemp throughout the nation by removing industrial hemp from the Controlled Substances Act. Hemp farms in the United States may have won a significant victory, but there are still obstacles to overcome when it comes to hemp.

 

This cannabis sativa plant has been used for many industrial purposes such as paper, oils, clothing, and building materials. One of hemp’s most popular products is Cannabidiol or CBD. Products containing CBD are becoming more popular for recreational and therapeutic uses and are being infused with products such as oils, creams, beverages, and food.

 

Marketers of these products have been claiming that the effects of CBD are curing ailments though research does not support those claims. There are many questions concerning whether or not certain CBD products are holding up to what vendors are claiming they do. The Food and Drug Administration is working to bridge the gap between science and snake oil by determining what claims can be lawfully made by a company about CBD products. The FDA requires premarket approval for any drug products that are marketed as therapeutic and contain CBD that make claims of diagnosing, preventing, or treating a disease.

 

When the 2018 Farm Bill was passed, the FDA built a website that would establish their goals for how they intend to regulate cannabis and the products derived from cannabis, which included CBD products. Some of the steps being taken, according to Scott Gottlieb, are that a group within the agency to explore potential pathways for the marketing of CBD products such as dietary supplements and food products. Changes may need to be made whether it is on a statutory or regulatory level and consideration of how much of an impact the marketing will have on the publics’ health.

 

Along with these changes, the FDA is also committing to taking action against any company that may be selling unapproved CBD products illegally. After reviewing companies websites with products containing CBD, they conclude if the company is violating the Federal Food, Drug, and Cosmetic Act. They are sending warning letters that inform companies they are illegally claiming their products prevent, diagnose, treat, or cure a disease. Since the market is growing quickly, the industry needs to create more product standards, so marketers know what can be claimed and what cannot.